AACR Annual Meeting 2017, 1 – 5 April 2017, Washington, DC, USA

AACR

1 kwietnia 2017

AACR Annual Meeting 2017, 1 - 5 April 2017, Washington, DC, USA

Rok

2017

Cel

RVU120 (CDK8/CDK19), daposertib (MEN1703 / SEL24), GCN2, PIM/FLT3, SHMT, SMARCA

plik pdf
"Development of small molecule selective inhibitors of GCN2 as an immunotherapy aimed at preventing immune escape of tumor cells"
Pobierz
plik pdf
"Differential activity on lung adenocarcinoma cells with loss-of-function mutations of SWI/SNF protein SMARCA4"
Pobierz
plik pdf
"Small molecule inhibitors of SHMT1/2 validate serine metabolism as a target in the treatment of c-Myc positive solid tumors"
Pobierz
plik pdf
"Inhibition of CDK8 kinase with SEL120-34A allows for a personalized approach in AML"
Pobierz
plik pdf
"Development of a potent, dual pan-PIM/FLT3 inhibitor for the treatment of heme malignancies"
Pobierz